Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD

NCT01334294 is registered in ClinicalTrials.gov with Notal Vision Ltd. as lead sponsor.

NCT NCT01334294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01334294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular AMD
Lead sponsor
Notal Vision Ltd.
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
March 31, 2014
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, choroidal neovascularization